Can vaccination of all adults slow down the second wave?
While Maharashtra is still reporting the most cases daily, there has been a slip dip in the last few days. It is a bit early to say if the second…
Category: Pfizer
How can India contain the second wave?
When do you think the second wave is likely to peak? And when we see such a peak, what do you think will be the number of daily cases? Gautam…
In a major shift, India fast-tracks restricted use approval for vaccines developed in other countries
The vaccines that would be eligible for the fast-track approval will include those that have been granted an EUA by the US Food and Drug Administration (FDA), European Medicines Agency…
Proving variant-specific efficacy will be a logistic nightmare, very expensive: Gagandeep Kang
What are the main challenges in developing and testing booster vaccine doses to address the new variants? Each variant (and many more beyond the first three that have been widely…
Pfizer vaccine can be stored at -15 to -25 degree C for two weeks
On December 11, 2020 when the U.S. FDA approved the vaccine for emergency use, the storage temperature stipulated was -60 to -80 degree C. The labels for the vaccine too…
Moderna, Pfizer vaccines neutralise variants encoding mutations E484K or N501Y but with less potency
The results were published in the journal Nature. Both Moderna and Pfizer-BioNTech vaccines showed no significant difference in neutralising activity. Individuals immunized with either Moderna or Pfizer-BioNTech vaccines produce closely…
Vaccine dilemma: To take or not to take Covaxin
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…
I would not take Covaxin without efficacy data: Gagandeep Kang
Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…
